Overview
Portfolio
More
Kikk Capital
Roosendaal, Netherlands
Focuses on early‑stage Dutch startups that have recently launched a product, process or service, providing hands‑on support drawing from the partners' own fast‑growth company experience.
Portfolio
20+
Employees
3+
Founded
2016
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
Netherlands
Sources
Kikk Capital
Focuses on early‑stage Dutch startups that have recently launched a product, process or service, providing hands‑on support drawing from the partners' own fast‑growth company experience.
Portfolio
20+
Employees
3+
Founded
2016
AUM
N/A
Stages
No stages listed
Industries
No industries listedGeographic scope
Netherlands
Sources
Showing 3 of 3 matched portfolio companies
Chromodynamics develops multispectral cameras capable of capturing real-time images detailing material composition. These cameras overcome traditional limitations by simultaneously delivering high resolution, speed, and a broad range of spectral bands. This technology supports advancements across life science research, diagnostics, and efficient manufacturing processes.
Funding: $2.3M
Rough estimate of the amount of funding raised
KIKK Capital
KIKK Capital
Funding: $2.3M
Rough estimate of the amount of funding raised
This company develops novel therapies for cardiovascular diseases by focusing on direct targeting of the heart muscle. They utilize expertise in bio-engineering and human induced pluripotent stem cells (hiPSC) to create advanced 3D cardiac in vitro models. These models support the discovery and development pipeline for new cardiac drugs.
Funding: $4.3M
Rough estimate of the amount of funding raised
BioGeneration VenturesKIKK Capital
BioGeneration VenturesKIKK Capital
Funding: $4.3M
Rough estimate of the amount of funding raised
Toxys provides mechanism-based in vitro assays, such as ToxTracker and ReproTracker, to assess genotoxicity and developmental toxicity of chemical compounds, enabling early identification of potential carcinogenic properties. Their services help pharmaceutical and chemical companies make informed decisions during product development, reducing reliance on animal testing and enhancing regulatory compliance.
Showing 12 of 17 unmatched portfolio companies